| UniProt ID | FOXJ3_HUMAN | |
|---|---|---|
| UniProt AC | Q9UPW0 | |
| Protein Name | Forkhead box protein J3 | |
| Gene Name | FOXJ3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 622 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Transcriptional activator of MEF2C involved in the regulation pf adult muscle fiber type identity and skeletal muscle regeneration.. | |
| Protein Sequence | MGLYGQACPSVTSLRMTSELESSLTSMDWLPQLTMRAAIQKSDATQNAHGTGISKKNALLDPNTTLDQEEVQQHKDGKPPYSYASLITFAINSSPKKKMTLSEIYQWICDNFPYYREAGSGWKNSIRHNLSLNKCFLKVPRSKDDPGKGSYWAIDTNPKEDVLPTRPKKRARSVERASTPYSIDSDSLGMECIISGSASPTLAINTVTNKVTLYNTDQDGSDSPRSSLNNSLSDQSLASVNLNSVGSVHSYTPVTSHPESVSQSLTPQQQPQYNLPERDKQLLFSEYNFEDLSASFRSLYKSVFEQSLSQQGLMNIPSESSQQSHTSCTYQHSPSSTVSTHPHSNQSSLSNSHGSGLNTTGSNSVAQVSLSHPQMHTQPSPHPPHRPHGLPQHPQRSPHPAPHPQQHSQLQSPHPQHPSPHQHIQHHPNHQHQTLTHQAPPPPQQVSCNSGVSNDWYATLDMLKESCRIASSVNWSDVDLSQFQGLMESMRQADLKNWSLDQVQFADLCSSLNQFFTQTGLIHSQSNVQQNVCHGAMHPTKPSQHIGTGNLYIDSRQNLPPSVMPPPGYPHIPQALSTPGTTMAGHHRAMNQQHMMPSQAFQMRRSLPPDDIQDDFDWDSIV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Phosphorylation | ----MGLYGQACPSV ----CCCCCCCCCCC | 11.06 | 24043423 | |
| 10 | Phosphorylation | LYGQACPSVTSLRMT CCCCCCCCCCCCCCC | 37.60 | 24043423 | |
| 12 | Phosphorylation | GQACPSVTSLRMTSE CCCCCCCCCCCCCHH | 26.78 | 24043423 | |
| 13 | Phosphorylation | QACPSVTSLRMTSEL CCCCCCCCCCCCHHH | 16.30 | 24043423 | |
| 17 | Phosphorylation | SVTSLRMTSELESSL CCCCCCCCHHHHHHC | 16.77 | 24043423 | |
| 18 | Phosphorylation | VTSLRMTSELESSLT CCCCCCCHHHHHHCC | 30.73 | 24043423 | |
| 22 | Phosphorylation | RMTSELESSLTSMDW CCCHHHHHHCCCCCH | 43.18 | 24043423 | |
| 23 | Phosphorylation | MTSELESSLTSMDWL CCHHHHHHCCCCCHH | 26.70 | 28348404 | |
| 25 | Phosphorylation | SELESSLTSMDWLPQ HHHHHHCCCCCHHHH | 24.77 | 28348404 | |
| 26 | Phosphorylation | ELESSLTSMDWLPQL HHHHHCCCCCHHHHH | 21.75 | 24043423 | |
| 34 | Phosphorylation | MDWLPQLTMRAAIQK CCHHHHHHHHHHHHH | 10.20 | 24043423 | |
| 41 | Acetylation | TMRAAIQKSDATQNA HHHHHHHHCHHCCCC | 44.16 | 25953088 | |
| 41 | Sumoylation | TMRAAIQKSDATQNA HHHHHHHHCHHCCCC | 44.16 | - | |
| 41 | Ubiquitination | TMRAAIQKSDATQNA HHHHHHHHCHHCCCC | 44.16 | 29967540 | |
| 41 | Sumoylation | TMRAAIQKSDATQNA HHHHHHHHCHHCCCC | 44.16 | - | |
| 45 | Phosphorylation | AIQKSDATQNAHGTG HHHHCHHCCCCCCCC | 27.61 | - | |
| 51 | Phosphorylation | ATQNAHGTGISKKNA HCCCCCCCCCCHHHC | 22.83 | - | |
| 55 | Ubiquitination | AHGTGISKKNALLDP CCCCCCCHHHCCCCC | 48.39 | 29967540 | |
| 55 | Acetylation | AHGTGISKKNALLDP CCCCCCCHHHCCCCC | 48.39 | 25953088 | |
| 56 | Ubiquitination | HGTGISKKNALLDPN CCCCCCHHHCCCCCC | 40.43 | 29967540 | |
| 64 | Phosphorylation | NALLDPNTTLDQEEV HCCCCCCCCCCHHHH | 33.84 | 28555341 | |
| 65 | Phosphorylation | ALLDPNTTLDQEEVQ CCCCCCCCCCHHHHH | 34.67 | 25159151 | |
| 81 | Phosphorylation | HKDGKPPYSYASLIT CCCCCCCCCHHHHHH | 23.88 | 20090780 | |
| 93 | Phosphorylation | LITFAINSSPKKKMT HHHHHHCCCCCCCCC | 41.74 | 28555341 | |
| 131 | Phosphorylation | NSIRHNLSLNKCFLK HHHHHCCCCCCEEEE | 34.90 | 21712546 | |
| 148 | Acetylation | RSKDDPGKGSYWAID CCCCCCCCCCEEEEC | 50.50 | 26051181 | |
| 148 | Ubiquitination | RSKDDPGKGSYWAID CCCCCCCCCCEEEEC | 50.50 | 29967540 | |
| 173 (in isoform 2) | Phosphorylation | - | 27.61 | 28450419 | |
| 173 | Phosphorylation | RPKKRARSVERASTP CCCHHCCCCCCCCCC | 27.61 | 28102081 | |
| 178 (in isoform 2) | Phosphorylation | - | 35.82 | 22617229 | |
| 178 | Phosphorylation | ARSVERASTPYSIDS CCCCCCCCCCCEECC | 35.82 | 27251275 | |
| 179 | Phosphorylation | RSVERASTPYSIDSD CCCCCCCCCCEECCC | 25.84 | 24719451 | |
| 180 (in isoform 2) | Phosphorylation | - | 20.55 | 23090842 | |
| 181 | Phosphorylation | VERASTPYSIDSDSL CCCCCCCCEECCCCC | 20.53 | 27251275 | |
| 182 | Phosphorylation | ERASTPYSIDSDSLG CCCCCCCEECCCCCC | 22.56 | 28857561 | |
| 187 (in isoform 2) | Phosphorylation | - | 30.67 | 25159151 | |
| 187 | Phosphorylation | PYSIDSDSLGMECII CCEECCCCCCCEEEE | 30.67 | 27251275 | |
| 189 (in isoform 2) | Phosphorylation | - | 17.50 | 25849741 | |
| 195 | Phosphorylation | LGMECIISGSASPTL CCCEEEEECCCCCCE | 13.54 | 27251275 | |
| 197 | Phosphorylation | MECIISGSASPTLAI CEEEEECCCCCCEEE | 20.84 | 30108239 | |
| 199 | Phosphorylation | CIISGSASPTLAINT EEEECCCCCCEEEEE | 21.80 | 28464451 | |
| 201 | Phosphorylation | ISGSASPTLAINTVT EECCCCCCEEEEECC | 26.73 | 27251275 | |
| 206 | Phosphorylation | SPTLAINTVTNKVTL CCCEEEEECCCEEEE | 23.69 | 27251275 | |
| 208 | Phosphorylation | TLAINTVTNKVTLYN CEEEEECCCEEEEEE | 27.55 | 27251275 | |
| 212 | Phosphorylation | NTVTNKVTLYNTDQD EECCCEEEEEECCCC | 25.74 | 30266825 | |
| 214 | Phosphorylation | VTNKVTLYNTDQDGS CCCEEEEEECCCCCC | 13.47 | 30266825 | |
| 216 | Phosphorylation | NKVTLYNTDQDGSDS CEEEEEECCCCCCCC | 22.83 | 30266825 | |
| 221 | Phosphorylation | YNTDQDGSDSPRSSL EECCCCCCCCCCHHH | 43.11 | 30266825 | |
| 223 | Phosphorylation | TDQDGSDSPRSSLNN CCCCCCCCCCHHHCC | 24.74 | 22167270 | |
| 239 | Phosphorylation | LSDQSLASVNLNSVG CCCCCCCCCCCCCCC | 19.48 | 28464451 | |
| 246 | Ubiquitination | SVNLNSVGSVHSYTP CCCCCCCCCEEECCC | 24.62 | 29967540 | |
| 260 | Phosphorylation | PVTSHPESVSQSLTP CCCCCCHHHHCCCCC | 31.36 | 26074081 | |
| 262 | Phosphorylation | TSHPESVSQSLTPQQ CCCCHHHHCCCCCCC | 24.27 | 26074081 | |
| 264 | Phosphorylation | HPESVSQSLTPQQQP CCHHHHCCCCCCCCC | 27.06 | 26074081 | |
| 266 | Phosphorylation | ESVSQSLTPQQQPQY HHHHCCCCCCCCCCC | 25.05 | 26074081 | |
| 273 | Phosphorylation | TPQQQPQYNLPERDK CCCCCCCCCCCHHHH | 25.91 | 26074081 | |
| 280 | Ubiquitination | YNLPERDKQLLFSEY CCCCHHHHHHHHCCC | 49.41 | 29967540 | |
| 285 | Phosphorylation | RDKQLLFSEYNFEDL HHHHHHHCCCCHHHH | 38.86 | 26074081 | |
| 293 | Phosphorylation | EYNFEDLSASFRSLY CCCHHHHHHHHHHHH | 33.90 | 28348404 | |
| 295 | Phosphorylation | NFEDLSASFRSLYKS CHHHHHHHHHHHHHH | 20.16 | 22817900 | |
| 350 | Phosphorylation | HSNQSSLSNSHGSGL CCCCCCCCCCCCCCC | 37.93 | 26074081 | |
| 352 | Phosphorylation | NQSSLSNSHGSGLNT CCCCCCCCCCCCCCC | 26.33 | 26074081 | |
| 471 | Phosphorylation | KESCRIASSVNWSDV HHHCCCCCCCCHHHC | 32.23 | 27251275 | |
| 472 | Phosphorylation | ESCRIASSVNWSDVD HHCCCCCCCCHHHCC | 15.50 | 22817900 | |
| 476 | Phosphorylation | IASSVNWSDVDLSQF CCCCCCHHHCCHHHH | 23.66 | 28102081 | |
| 489 | Phosphorylation | QFQGLMESMRQADLK HHHHHHHHHHHHHHH | 12.80 | 22817900 | |
| 606 | Phosphorylation | QAFQMRRSLPPDDIQ HHHHHHHCCCCCCCC | 34.56 | 10470851 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FOXJ3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FOXJ3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FOXJ3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ALBU_HUMAN | ALB | physical | 25609649 | |
| P53_HUMAN | TP53 | physical | 25609649 | |
| RAGP1_HUMAN | RANGAP1 | physical | 25609649 | |
| SMCA5_HUMAN | SMARCA5 | physical | 25609649 | |
| UBR2_HUMAN | UBR2 | physical | 25609649 | |
| ZBT10_HUMAN | ZBTB10 | physical | 25609649 | |
| RFA2_HUMAN | RPA2 | physical | 25609649 | |
| UBP11_HUMAN | USP11 | physical | 25609649 | |
| FOXJ1_HUMAN | FOXJ1 | physical | 25609649 | |
| PSB4_HUMAN | PSMB4 | physical | 25609649 | |
| ZBTB2_HUMAN | ZBTB2 | physical | 25609649 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-223; SER-295 ANDSER-489, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-223, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-223, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-223, AND MASSSPECTROMETRY. | |